Sheikh Abdullah Tasaduq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sheikh Abdullah Tasaduq has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
Aalim Maqsood Bhat
Pharmacology Division, Council of Scientific and Industrial Research-Indian Institute of Integrative Medicine, Jammu, India
10 shared publicationsHaroon Rashid
Pharmacology Division, Council of Scientific and Industrial Research-Indian Institute of Integrative Medicine, Jammu, India
9 shared publicationsLove Sharma
Biological Sciences, Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
8 shared publicationsRather A. Rafiq
CSIR-Indian Institute of Integrative Medicine
8 shared publicationsA.K. Saxena
6 shared publicationsAbdul Faruk
6 shared publications
Latest Publications
- 27 October 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 84 (1) , 1193-1206
Multifaceted Stress Induction and Autophagic Flux Disruption by Shikonin Amplify Apoptotic Death in Melanoma Cells
- 27 October 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 84 (1) , 1193-1206
Multifaceted Stress Induction and Autophagic Flux Disruption by Shikonin Amplify Apoptotic Death in Melanoma Cells
- Open Access
- 9 October 2025
- Published by Elsevier in Experimental Gerontology
- Vol. 211, 112922
Antioxidant-induced autophagy ameliorates oxidative mediated endoplasmic reticulum stress in ultraviolet-B-exposed human primary dermal fibroblasts
- 9 October 2025
- Published by Elsevier in Experimental Gerontology
- Vol. 211, 112922
Open AccessAntioxidant-induced autophagy ameliorates oxidative mediated endoplasmic reticulum stress in ultraviolet-B-exposed human primary dermal fibroblasts
- 23 September 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-24
Unravelling the role of melanogenesis in melanoma: oncogenic crosstalk and therapeutic prospects
- 23 September 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-24
Unravelling the role of melanogenesis in melanoma: oncogenic crosstalk and therapeutic prospects
- 25 August 2025
- Published by Springer Nature in Cytotechnology
- Vol. 77 (5) , 1-18
A novel liphagal analog, IIIM-321, induces apoptosis in melanoma cells via autophagy modulation and PI3K/MAPK pathway inhibition
Melanoma is an aggressive and highly metastatic skin cancer characterized by high mortality and resistance to conventional chemotherapy. Aberrant activation of the PI3K and MAPK signaling pathways in melanoma cells enhances survival and drives tumor progression. Targeting autophagy has emerged as a novel therapeutic strategy to induce cell death in melanoma. In this study, we evaluated IIIM-321, a synthetically derived lipidated analog of liphagal, which effectively downregulated both MAPK and PI3K signaling pathways, leading to a time- and dose-dependent reduction in melanoma cell proliferation. IIIM-321 induced significant pro-apoptotic effects in B16F10 cells, accompanied by autophagy inhibition, reactive oxygen species (ROS) accumulation, modulation of antioxidant defenses, and mitochondrial membrane potential (ΔΨM) disruption. The compound induced G0/G1 cell cycle arrest through upregulation of p21, downregulation of Cyclin D1, and its degradation via phosphorylated GSK3β, ultimately triggering apoptosis. Apoptotic induction was further confirmed by annexin-V/PI staining, cytochrome c release, caspase activation, and PARP cleavage. IIIM-321-mediated autophagy inhibition was evidenced by increased LC3-II, decreased Beclin1, and p62/SQSTM1 accumulation. These findings were supported by acridine orange staining and immunocytochemistry for Beclin1 and p62. Additionally, IIIM-321 suppressed both basal and α-MSH-stimulated melanogenesis in B16F10 cells, along with reduced expression of Tyrosinase, Trp-1, and Trp-2. Collectively, our findings establish IIIM-321 as a promising anti-melanoma agent with therapeutic potential for future clinical development. Graphical abstract
- 25 August 2025
- Published by Springer Nature in Cytotechnology
- Vol. 77 (5) , 1-18
A novel liphagal analog, IIIM-321, induces apoptosis in melanoma cells via autophagy modulation and PI3K/MAPK pathway inhibition
Melanoma is an aggressive and highly metastatic skin cancer characterized by high mortality and resistance to conventional chemotherapy. Aberrant activation of the PI3K and MAPK signaling pathways in melanoma cells enhances survival and drives tumor progression. Targeting autophagy has emerged as a novel therapeutic strategy to induce cell death in melanoma. In this study, we evaluated IIIM-321, a synthetically derived lipidated analog of liphagal, which effectively downregulated both MAPK and PI3K signaling pathways, leading to a time- and dose-dependent reduction in melanoma cell proliferation. IIIM-321 induced significant pro-apoptotic effects in B16F10 cells, accompanied by autophagy inhibition, reactive oxygen species (ROS) accumulation, modulation of antioxidant defenses, and mitochondrial membrane potential (ΔΨM) disruption. The compound induced G0/G1 cell cycle arrest through upregulation of p21, downregulation of Cyclin D1, and its degradation via phosphorylated GSK3β, ultimately triggering apoptosis. Apoptotic induction was further confirmed by annexin-V/PI staining, cytochrome c release, caspase activation, and PARP cleavage. IIIM-321-mediated autophagy inhibition was evidenced by increased LC3-II, decreased Beclin1, and p62/SQSTM1 accumulation. These findings were supported by acridine orange staining and immunocytochemistry for Beclin1 and p62. Additionally, IIIM-321 suppressed both basal and α-MSH-stimulated melanogenesis in B16F10 cells, along with reduced expression of Tyrosinase, Trp-1, and Trp-2. Collectively, our findings establish IIIM-321 as a promising anti-melanoma agent with therapeutic potential for future clinical development. Graphical abstract
- Open Access
- 21 July 2025
- Published by Wolters Kluwer Health in Indian Journal of Pharmacology
- Vol. 57 (4) , 234-241
Co-treatment of trigonelline and everolimus synergistically prevented chronic steatohepatitis induced by fast food diet and thioacetamide in a novel murine nonalcoholic steatohepatitis model
OBJECTIVES: Nonalcoholic steatohepatitis (NASH) is a strong risk factor for end-stage liver disease. Trigonelline (TG) is a plant alkaloid with anti-oxidant, anti-dyslipidemic, and anti-insulin resistance activities. Everolimus (EV), a conventional drug and an mTOR inhibitor, has been demonstrated to improve metabolic outcomes. The synergistic effect of the co-treatment of TG and EV against NASH conditions remains unknown. MATERIALS AND METHODS: We have developed a fast food (FF)-diet and thioacetamide-induced chronic steatohepatitis in a C57BL/6J mice model of 24 weeks duration. We have evaluated the synergistic protective effect of TG and EV at reduced doses to avoid any undesired toxic manifestations of the FF and thioacetamide. The study was demonstrated by comparative analysis across different groups after 24 weeks. RESULTS: Co-exposure to FF diet and thioacetamide resulted in chronic steatohepatitis, evident by focal necrosis, bridging fibrosis, loss of liver architecture, and excessive collagen deposition. Protein and gene analysis revealed enhanced de novo lipogenesis (SREBP-1, PPAR-Ƴ, CD36), inflammation (interleukin-6, tumor necrosis factor, CYP2E1), fibrosis (transforming growth factor beta, alpha-smooth muscle actin, tissue inhibitors of metalloproteinases-1), and extracellular matrix deposition (MMP-1, Col1A1). TG + EV at reduced doses showed marked synergistic effects in preventing inflammation, fibrosis, and lipogenesis markers. CONCLUSION: This study provides a novel 24-week FF diet and thioacetamide-induced murine NASH model for possible preclinical drug discovery studies. Furthermore, our treatment regimen discovered the synergistic effect of TG and EV at reduced doses in preventing chronic steatohepatitis.
- 21 July 2025
- Published by Wolters Kluwer Health in Indian Journal of Pharmacology
- Vol. 57 (4) , 234-241
Open AccessCo-treatment of trigonelline and everolimus synergistically prevented chronic steatohepatitis induced by fast food diet and thioacetamide in a novel murine nonalcoholic steatohepatitis model
OBJECTIVES: Nonalcoholic steatohepatitis (NASH) is a strong risk factor for end-stage liver disease. Trigonelline (TG) is a plant alkaloid with anti-oxidant, anti-dyslipidemic, and anti-insulin resistance activities. Everolimus (EV), a conventional drug and an mTOR inhibitor, has been demonstrated to improve metabolic outcomes. The synergistic effect of the co-treatment of TG and EV against NASH conditions remains unknown. MATERIALS AND METHODS: We have developed a fast food (FF)-diet and thioacetamide-induced chronic steatohepatitis in a C57BL/6J mice model of 24 weeks duration. We have evaluated the synergistic protective effect of TG and EV at reduced doses to avoid any undesired toxic manifestations of the FF and thioacetamide. The study was demonstrated by comparative analysis across different groups after 24 weeks. RESULTS: Co-exposure to FF diet and thioacetamide resulted in chronic steatohepatitis, evident by focal necrosis, bridging fibrosis, loss of liver architecture, and excessive collagen deposition. Protein and gene analysis revealed enhanced de novo lipogenesis (SREBP-1, PPAR-Ƴ, CD36), inflammation (interleukin-6, tumor necrosis factor, CYP2E1), fibrosis (transforming growth factor beta, alpha-smooth muscle actin, tissue inhibitors of metalloproteinases-1), and extracellular matrix deposition (MMP-1, Col1A1). TG + EV at reduced doses showed marked synergistic effects in preventing inflammation, fibrosis, and lipogenesis markers. CONCLUSION: This study provides a novel 24-week FF diet and thioacetamide-induced murine NASH model for possible preclinical drug discovery studies. Furthermore, our treatment regimen discovered the synergistic effect of TG and EV at reduced doses in preventing chronic steatohepatitis.
- Open Access
- 25 May 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (10) , 1774-1777
Photophagy: Unveiling a Novel Cellular Mechanism in UVB ‐Induced Skin Aging and Resilience
- 25 May 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (10) , 1774-1777
Open AccessPhotophagy: Unveiling a Novel Cellular Mechanism in UVB ‐Induced Skin Aging and Resilience
- Open Access
- 2 April 2025
- Published by IntechOpen
Apoptosis-Mechanisms, Regulation in Pathology, and Therapeutic Potential
Apoptosis, a highly regulated form of programmed cell death (PCD), is essential for development, tissue homeostasis, and the immune response. This self-destructive process is characterized by distinct cellular changes, including membrane blebbing, chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies. Apoptosis can be triggered by two primary signaling pathways: the intrinsic (mitochondrial) pathway, responding to internal cellular stress, and the extrinsic (death receptor) pathway, initiated by external signals. Both pathways ultimately activate caspases, proteolytic enzymes that dismantle the cell in an orderly manner, preventing inflammation. The intrinsic pathway is regulated by the Bcl-2 protein family, balancing pro-apoptotic and anti-apoptotic signals to maintain cellular integrity, while mitochondrial disruptions lead to the release of cytochrome c and activation of downstream apoptotic machinery. Dysregulation of apoptosis is linked to various diseases, including cancer, where defective apoptotic processes allow uncontrolled cell proliferation, and neurodegenerative disorders, where excessive apoptosis leads to cell loss. This review offers an in-depth understanding of apoptosis, and its regulatory mechanisms offer crucial insights for therapeutic approaches targeting apoptosis in diseases characterized by abnormal cell survival or death.
- 2 April 2025
- Published by IntechOpen
Open AccessApoptosis-Mechanisms, Regulation in Pathology, and Therapeutic Potential
Apoptosis, a highly regulated form of programmed cell death (PCD), is essential for development, tissue homeostasis, and the immune response. This self-destructive process is characterized by distinct cellular changes, including membrane blebbing, chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies. Apoptosis can be triggered by two primary signaling pathways: the intrinsic (mitochondrial) pathway, responding to internal cellular stress, and the extrinsic (death receptor) pathway, initiated by external signals. Both pathways ultimately activate caspases, proteolytic enzymes that dismantle the cell in an orderly manner, preventing inflammation. The intrinsic pathway is regulated by the Bcl-2 protein family, balancing pro-apoptotic and anti-apoptotic signals to maintain cellular integrity, while mitochondrial disruptions lead to the release of cytochrome c and activation of downstream apoptotic machinery. Dysregulation of apoptosis is linked to various diseases, including cancer, where defective apoptotic processes allow uncontrolled cell proliferation, and neurodegenerative disorders, where excessive apoptosis leads to cell loss. This review offers an in-depth understanding of apoptosis, and its regulatory mechanisms offer crucial insights for therapeutic approaches targeting apoptosis in diseases characterized by abnormal cell survival or death.
- 10 July 2024
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 31 (34) , 46979-46993
Seabuckthorn pulp extract alleviates UV-B-induced skin photo-damage by significantly reducing oxidative stress-mediated endoplasmic reticulum stress and DNA Damage in human primary skin fibroblasts and Balb/c mice skin
Skin homeostasis is predominantly compromised by exposure to UV-B irradiation, leading to several physiopathological processes at cellular and tissue levels that deteriorate skin function and integrity. The current study investigated the photo-protective role of seabuckthorn fruit pulp (SBT) extract against UV-B-induced damage in primary human skin fibroblasts (HDFs) and Balb/C mice skin. We subjected HDFs and Balb/C mice to UV-B irradiation and measured multiple cellular damage indicators. We found that UV-B-irradiated HDFs treated with SBT had a considerably greater survival rate than cells exposed to UV-B radiation alone. The UV-B irradiation–induced ROS generation led to the degradation of the extracellular matrix, inflammation, DNA damage, endoplasmic reticulum (ER) stress, and apoptosis. SBT treatment significantly reduced these manifestations. Topical application of SBT alleviated UV-B-induced epidermal thickening, leukocyte infiltration, and degradation of extracellular matrix in Balb/c mice skin. Based on our results, we conclude that SBT has the potential to be developed as a therapeutic/cosmetic remedy for the prevention of skin photo-damage.
- 10 July 2024
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 31 (34) , 46979-46993
Seabuckthorn pulp extract alleviates UV-B-induced skin photo-damage by significantly reducing oxidative stress-mediated endoplasmic reticulum stress and DNA Damage in human primary skin fibroblasts and Balb/c mice skin
Skin homeostasis is predominantly compromised by exposure to UV-B irradiation, leading to several physiopathological processes at cellular and tissue levels that deteriorate skin function and integrity. The current study investigated the photo-protective role of seabuckthorn fruit pulp (SBT) extract against UV-B-induced damage in primary human skin fibroblasts (HDFs) and Balb/C mice skin. We subjected HDFs and Balb/C mice to UV-B irradiation and measured multiple cellular damage indicators. We found that UV-B-irradiated HDFs treated with SBT had a considerably greater survival rate than cells exposed to UV-B radiation alone. The UV-B irradiation–induced ROS generation led to the degradation of the extracellular matrix, inflammation, DNA damage, endoplasmic reticulum (ER) stress, and apoptosis. SBT treatment significantly reduced these manifestations. Topical application of SBT alleviated UV-B-induced epidermal thickening, leukocyte infiltration, and degradation of extracellular matrix in Balb/c mice skin. Based on our results, we conclude that SBT has the potential to be developed as a therapeutic/cosmetic remedy for the prevention of skin photo-damage.
- 20 May 2024
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 256, 112944
Naringenin, a flavanone constituent from Sea buckthorn pulp extract, prevents ultraviolet (UV)-B radiation-induced skin damage via alleviation of impaired mitochondrial dynamics mediated inflammation in human dermal fibroblasts and Balb/c mice models
- 20 May 2024
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 256, 112944
Naringenin, a flavanone constituent from Sea buckthorn pulp extract, prevents ultraviolet (UV)-B radiation-induced skin damage via alleviation of impaired mitochondrial dynamics mediated inflammation in human dermal fibroblasts and Balb/c mice models